Advertisement

Hibiscus sabdariffa Extract Inhibits Adhesion, Biofilm Initiation and Formation in Candida albicans

  • Meenakshi DwivediEmail author
  • Sumathi Muralidhar
  • Daman Saluja
Original research article

Abstract

Microbial biofilms act as reservoirs for pathogenic sessile microbes which reside inside the three dimensional matrix of the biofilm, and are thus protected against anti-microbial drugs. Most of the anti-microbial drugs fail to completely abolish the biofilm associated infections. In the present study, we provide evidence of Hibiscus sabdariffa (Hs) extract having possible anti-microbial activity, with emphasis on Candida albicans biofilm. The Hs extract was shown to be effective against C. albicans pre-formed biofilm at 3.125 mg/ml and was able to inhibit the hyphae initiation and adherence of cells. Furthermore, Hs extract was able to reduce the C. albicans load in C. elegans by effectively killing the Candida cells thereby reducing the viable colony count and effectively increasing the lifespan of worms. The percentage of viable hatched progeny of worms exposed to Hs extract (both at conc. 1.5 mg/ml and 6.25 mg/ml), was also comparable to that of the control untreated eggs. The Hs extract was also found to be significantly effective against fluconazole resistant C. albicans isolated from patients. Thus, we, for the first time, propose Hs extract as a prospective drug candidate and substitute for eradicating pre-formed biofilm and inhibiting the growth of C. albicans.

Keywords

Candida albicans Bio-film Hibiscus sabdariffa Natural products Caenorhabditis elegans 

Abbreviations

CFU

Colony-forming units

DMSO

Dimethyl sulfoxide

Hs

Hibiscus sabdariffa

MDR

Multi drug resistant

MIC

Minimum inhibitory concentration

NP

Natural products

XTT

2,3-bis(2-methoxy-4-nitro-5-sulfo-phenyl)-2H-tetrazolium-5-carboxanilide

Notes

Acknowledgements

The authors are thankful to the DBT-BIF bioinformatics facility of ACBR for all the logistic support. Strains used in this study were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440).

Funding

This work was supported by the scheme of Post Doctoral Fellowship for Women funded by University Grants Commission, India (Grant No. PDFWM-2014-15-GE-DEL-22743) to MD and SAPII by UGC and DST-Purse Grant-II to DS funded by Department of Science and Technology, India.

Compliance with Ethical Standards

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical Approval

The study protocol was as per the Guidelines and Standards for Research. The study was approved by the Ethics Committee of ACBR (ACBR/IHEC/DS-02/09-18), University of Delhi and VMMC and Safdarjung Hospital (IEC/VMMC/SJH/Project/November/2018-1104).

References

  1. 1.
    Chandra J, Mukherjee PK (2015) Candida biofilms: development, architecture, and resistance. Microbiol Spectr.  https://doi.org/10.1128/microbiolspec.MB-0020-2015 CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Silva S, Rodrigues CF, Araújo D, Rodrigues ME, Henriques M (2017) Candida species biofilms’ antifungal resistance. J Fungi 3:8.  https://doi.org/10.3390/jof3010008 CrossRefGoogle Scholar
  3. 3.
    Dongari-Bagtzoglou A (2008) Pathogenesis of mucosal biofilm infections: challenges and progress. Expert Rev Anti Infect Ther 6:201–208.  https://doi.org/10.1586/14787210.6.2.201 CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Newman DJ, Cragg GM (2016) Natural products as sources of new drugs from 1981 to 2014. J Nat Prod 79:629–661.  https://doi.org/10.1021/acs.jnatprod.5b01055 CrossRefPubMedGoogle Scholar
  5. 5.
    Elisha IL, Botha FS, McGaw LJ, Eloff JN (2017) The antibacterial activity of extracts of nine plant species with good activity against Escherichia coli against five other bacteria and cytotoxicity of extracts. BMC Complement Altern Med 17:133.  https://doi.org/10.1186/s12906-017-1645-z CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Vashist H, Jindal A (2012) Antimicrobial activities of medicinal plants—review. Int J Res Pharm Biomed Sci 3:222–230Google Scholar
  7. 7.
    Silva N, Fernandes Júnior A (2010) Biological properties of medicinal plants: a review of their antimicrobial activity. J Venom Anim Toxins Incl Trop Dis 16:402–413.  https://doi.org/10.1590/S1678-91992010000300006 CrossRefGoogle Scholar
  8. 8.
    Kusumoto IT, Nakabayashi T, Kida H, Miyashiro H, Hattori M, Namba T, Shimotohno K (1995) Screening of various plant extracts used in ayurvedic medicine for inhibitory effects on human immunodeficiency virus type 1 (HIV-1) protease. Phyther Res 9:180–184.  https://doi.org/10.1002/ptr.2650090305 CrossRefGoogle Scholar
  9. 9.
    Hassan STS, Berchová K, Šudomová M (2016) Antimicrobial, antiparasitic and anticancer properties of Hibiscus sabdariffa (L.) and its phytochemicals: in vitro and in vivo studies. Ceska Slov Farm 65:10–14PubMedGoogle Scholar
  10. 10.
    Panaitescu M, Lengyel E (2017) Monitoring the antibacterial activity of Hibiscus sabdariffa extracts. Manag Sustain Dev 9:31–34.  https://doi.org/10.1515/msd-2017-0011 CrossRefGoogle Scholar
  11. 11.
    Afolabi OC, Ogunsola FT, Coker AO (2008) Susceptibility of cariogenic Streptococcus mutans to extracts of Garcinia kola, Hibiscus sabdariffa, and Solanum americanum. West Afr J Med 27:230–233PubMedGoogle Scholar
  12. 12.
    Olaleye TM (2007) Cytotoxicity and antibacterial activity of methanolic extract of Hibiscus sabdariffa. J Med Plants Res 1:009–013Google Scholar
  13. 13.
    Wayne P (2006) Performance standards for antimicrobial disk susceptibility tests; approved standard, 9th edn. Clinical and Laboratory Standards Institute, Wayne, PAGoogle Scholar
  14. 14.
    Borrás-Linares I, Fernández-Arroyo S, Arráez-Roman D, Palmeros-Suárez PA, Del Val-Díaz R, Andrade-Gonzáles I, Fernandez-Gutierrez A, Gomez-Leyva JF, Segura-Carretero A (2015) Characterization of phenolic compounds, anthocyanidin, antioxidant and antimicrobial activity of 25 varieties of Mexican Roselle (Hibiscus sabdariffa). Ind Crops Prod 69:385–394.  https://doi.org/10.1016/j.indcrop.2015.02.053 CrossRefGoogle Scholar
  15. 15.
    Rex JH, Alexander BD, Andes D, Arthington-Skaggs B, Brown SD, Chaturvedi V, Ghannoum MA, Espinel-Ingroff A, Knapp CC, Ostrosky-Zeichner L, Pfaller MA, Sheehan DJ, Walsh TJ (2008) Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard, 3rd edn. Clinical and Laboratory Standards Institute, Wayne, pp 1–25.  https://doi.org/10.4319/lo.1981.26.3.0590 CrossRefGoogle Scholar
  16. 16.
    Pierce CG, Uppuluri P, Tristan AR, Wormley FL, Mowat E, Ramage G, Lopez-Ribot JL (2008) A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc 3:1494–1500.  https://doi.org/10.1038/nprot.2008.141 CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Chandra J, Mukherjee PK, Ghannoum MA (2008) In vitro growth and analysis of Candida biofilms. Nat Protoc 3:1909–1924.  https://doi.org/10.1038/nprot.2008.192 CrossRefPubMedGoogle Scholar
  18. 18.
    Fazly A, Jain C, Dehner AC, Issi L, Lilly EA, Ali A, Cao H, Fidel PL Jr, Kaufman PD (2013) Chemical screening identifies filastatin, a small molecule inhibitor of Candida albicans adhesion, morphogenesis, and pathogenesis. Proc Natl Acad Sci 110:13594–13599.  https://doi.org/10.1073/pnas.1305982110 CrossRefPubMedGoogle Scholar
  19. 19.
    Breger J, Fuchs BB, Aperis G, Moy TI, Ausubel FM, Mylonakis E (2007) Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathog 3:e18.  https://doi.org/10.1371/journal.ppat.0030018 CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Riaz G, Chopra R (2018) A review on phytochemistry and therapeutic uses of Hibiscus sabdariffa L. Biomed Pharmacother 102:575–586.  https://doi.org/10.1016/j.biopha.2018.03.023 CrossRefPubMedGoogle Scholar
  21. 21.
    Abdallah EM (2016) Antibacterial activity of Hibiscus sabdariffa L. calyces against hospital isolates of multidrug resistant Acinetobacter baumannii. J Acute Dis 5:512–516.  https://doi.org/10.1016/j.joad.2016.08.024 CrossRefGoogle Scholar
  22. 22.
    Abdallah EM (2016) Antibacterial efficiency of the Sudanese Roselle (Hibiscus sabdariffa L.), a famous beverage from Sudanese folk medicine. J Intercult Ethnopharmacol 5:186–190.  https://doi.org/10.5455/jice.20160320022623 CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Ramirez-Rodrigues MM, Plaza ML, Azeredo A, Balaban MO, Marshall MR (2011) Physicochemical and phytochemical properties of cold and hot water extraction from Hibiscus sabdariffa. J Food Sci 76:429–435.  https://doi.org/10.1111/j.1750-3841.2011.02091.x CrossRefGoogle Scholar
  24. 24.
    Ramírez-Rodrigues MM, Balaban MO, Marshall MR, Rouseff RL (2011) Hot and cold water infusion aroma profiles of Hibiscus sabdariffa: fresh compared with dried. J Food Sci 76:212–217.  https://doi.org/10.1111/j.1750-3841.2010.01989.x CrossRefGoogle Scholar
  25. 25.
    Fullerton M, Khatiwada J, Johnson JU, Davis S, Williams LL (2011) Determination of antimicrobial activity of sorrel (Hibiscus sabdariffa) on Esherichia coli O157:H7 isolated from food, veterinary, and clinical samples. J Med Food 14:950–956.  https://doi.org/10.1089/jmf.2010.0200 CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Biswas S, Van Dijck P, Datta A (2007) Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. Microbiol Mol Biol Rev 71:348–376.  https://doi.org/10.1128/MMBR.00009-06 CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Ernst JF (2000) Transcription factors in Candida albicans—environmental control of morphogenesis. Microbiology 146:1763–1774.  https://doi.org/10.1099/00221287-146-8-1763 CrossRefPubMedGoogle Scholar
  28. 28.
    Rukayadi Y, Shim J-S, Hwang J-K (2008) Screening of Thai medicinal plants for anticandidal activity. Mycoses 51:308–312.  https://doi.org/10.1111/j.1439-0507.2008.01497.x CrossRefPubMedGoogle Scholar
  29. 29.
    Alshami I, Alharbi AE (2014) Hibiscus sabdariffa extract inhibits in vitro biofilm formation capacity of Candida albicans isolated from recurrent urinary tract infections. Asian Pac J Trop Biomed 4:104–108.  https://doi.org/10.1016/S2221-1691(14)60217-3 CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Hunt PR (2017) The C. elegans model in toxicity testing. J Appl Toxicol 37:50–59.  https://doi.org/10.1002/jat.3357 CrossRefPubMedGoogle Scholar
  31. 31.
    Gauwerky K, Borelli C, Korting HC (2009) Targeting virulence: a new paradigm for antifungals. Drug Discov Today 14:214–222.  https://doi.org/10.1016/j.drudis.2008.11.013 CrossRefPubMedGoogle Scholar

Copyright information

© Association of Microbiologists of India 2019

Authors and Affiliations

  1. 1.Medical Biotechnology Laboratory, Dr. B. R. Ambedkar Centre for Biomedical Research (ACBR)University of DelhiDelhiIndia
  2. 2.Apex-Regional STD Centre and State Reference Laboratory for HIV, Department of Microbiology, Vardhman Mahavir Medical CollegeSafdarjung HospitalNew DelhiIndia

Personalised recommendations